Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study
Sarah E. Holden; Christopher Ll. Morgan; Qing Qiao; Sara Jenkins‐Jones; Ellen R. Berni; Craig J. Currie
Author Information: Pharmatelligence
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.